Molecular Pharmaceutics · 2007 · 30 citations · 9 references
Life SciencesBiochemistryBiophysicsProtein BiochemistryStructural BiochemistryStructural BiologyMacromolecular AssemblyProtein CharacterizationProtein Complex AnalysisProtein Complex AssemblyProtein StructureStable Protein ComplexesBotulinum NeurotoxinBotulinum ToxinsCircular DichroismPhase Diagram InterpretationProtein Complex StabilityProtein Stability AnalysisToxin BiochemistryToxin Structure
Clostridium botulinum type A neurotoxin (BoNT/A complex) is of great interest to the pharmaceutical industry. The drug itself is a natural complex of the toxin and a number of associated proteins. Surprisingly, relatively little is known about the exact structure and stability of the 900 kDa BoNT/A complex and its component proteins with the exception of the 150 kDa neurotoxin. In this study we describe the relative stability of the BoNT/A complex, the neurotoxin, and its associated proteins over a wide range of temperature and pH employing circular dichroism, intrinsic and 8-anilino-1-naphthalene sulfonate (ANS) fluorescence, and static light scattering. The data suggest a strong stabilizing effect of the associated proteins on the neurotoxin component. This data is compiled into empirical phase diagrams which permit the simultaneous visualization of multiple data sets over a wide range of conditions.
9
Molecular composition of Clostridium botulinum type A progenitor toxins
Kaoru Inoue, Yukako Fujinaga, Tatsuo Watanabe et al. · Infection and Immunity · 1996 · 204 citations · Full text
Ann Hunt, Kapil D. Sethi · Movement Disorders · 2006 · 78 citations
A molecular basis underlying differences in the toxicity of botulinum serotypes A and E
Mark Bajohrs, Colin Rickman, Thomas Binz et al. · EMBO Reports · 2004 · 69 citations · Full text